Body Awareness Therapy and Biomarkers in Fibromyalgia

Recruiting now · Not applicable

Conditions studied: Fibromyalgia

In brief

A randomized trial of Basic Body Awareness Therapy (BBAT) is applied in fibromyalgia patients as compared with a control intervention consisting of stretching. Sessions of BBAT lasted 90 min each and took place twice a week form 12 weeks. The primary end point is a change in the biomarkers and neurotransmitters and the Fibromyalgia Impact Questionnaire and the secondary end points include Visual Analog Scale, State Trait Anxiety inventory, Beck Depression Inventory. All assessments will be repeated at post treatment, 12 and 24 weeks and 1 year follow-up.

Key facts

Study ID

NCT05555394

Run by

Universitat de Lleida

People needed

110

Starts

2024-05-08

Expected to finish

2025-09-01

Last updated by the study team

2025-05-08

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• whose diagnosed of fibromyalgia almost 6 months before
• whose could be in different position such as lying, sitting, and stand-up

You may not qualify if…

• whose are diagnosed of disease that it worse the pain
• pregnancy
• whose are diagnosed of other disease such as rheumatology, neurology, cardiac problems o another internal medical condition,malignant disease or acute infections

Where it is running

• Consorci Sanitari de l'Anoia — Igualada, Barcelona, Spain (enrolling)
• Cristina Bravo Navarro — Igualada, Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.